-
Abstract Number: OC 62.3
Obstetric Analgesia and Anaesthesia in Women with Inherited Bleeding Disorders
-
Abstract Number: PB0665
Off-label Use of Emicizumab in Persons with Acquired Hemophilia A and von Willebrand Disease: A Scoping Review of the Literature
-
Abstract Number: PB0087
Off-label Use of Prothrombin Complex Concentrate in the Clinical Practice of a Portuguese Tertiary Hospital
-
Abstract Number: PB0826
Off-label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature
-
Abstract Number: PB0639
Off-pump Coronary Artery Bypass Graft Management in a Severe Hemophilia B Patient
-
Abstract Number: PB0123
On the Diagnosis of Thrombinemia in the Arctic
-
Abstract Number: PO135
On the Issue of Thrombinemia in Moderate COVID-19
-
Abstract Number: PB0797
Once a Day Compared to Twice a Day Enoxaparin in Children with Venous Thromboembolism: A Single Center Experience
-
Abstract Number: OC 63.3
Optimization of Calf Pump Function Measurements by Venous Plethysmography for Prediction of Deep Vein Thrombosis
-
Abstract Number: PB0276
Optimization of Operational Flow of D-dimer Test in a Core Laboratory in a Brazilian Tertiary Hospital to Ensure Operational Efficiency during the COVID-19 Pandemic
-
Abstract Number: PB0459
Optimization of Thrombin Generation for Hemophilia A
-
Abstract Number: PB0102
Optimizing Variant Curation Guidelines to Improve Clinical Genetic Testing for Hemophilia A and B
-
Abstract Number: PB1254
Oral Anticoagulant Use in Patients with Morbid Obesity: A Systemic Review and Meta-analysis
-
Abstract Number: PB0254
Oral Anticoagulation with Rivaroxaban as Thromboprophylaxis in Patients Recovered from COVID-19 Pneumonia in Veracruz, Mexico
-
Abstract Number: OC 38.2
Oral Delivery of Factor VIII Reduces the Magnitude of the Anti-FVIII Immune Response and Increases Splenic Treg Numbers
-
Abstract Number: OC 59.1
Oral Pazopanib Results in Durable Hemostasis in Patients with Severe Bleeding and RBC Transfusion-dependent Hereditary Hemorrhagic Telangiectasia
-
Abstract Number: OC 48.4
Orally Delivered Factor VIII Restores Hemostasis in a Hemophilia A Dog
-
Abstract Number: OC 44.4
Origin of Antiphospholipid Antibodies in Autoimmunity and Viral Infection
-
Abstract Number: LPB0089
Outcome of Cancer-associated Venous Thromboembolism Is More Favourable among Patients with Hematologic Malignancies than with Solid Tumors
-
Abstract Number: OC 25.4
Outcomes Associated with Mandatory Venous Thromboembolism (VTE) Risk Assessment in General Obstetric and Gynecologic Patients
-
Abstract Number: PB0695
Outcomes of a Bleeding Disorders Diagnostic Multi-disciplinary Team Meeting for Diagnosing Unclassified Bleeding Disorder / Bleeding of Unknown Cause
-
Abstract Number: PB1236
Outcomes of Non-bleeding Patients on Warfarin with an INR > 10, who Received Vitamin K or Conservative Therapy
-
Abstract Number: PB0788
Outcomes of Prophylactic Enoxaparin against Venous Thromboembolism in Hospitalized Children
-
Abstract Number: OC 53.3
Outcomes of Subsequent Pregnancy in Women with a History of Immune Thrombotic Thrombocytopenic Purpura
-
Abstract Number: PB1307
Outcomes of Treatment of Thromboembolic Disease during Pregnancy and Postpartum – Single-center Experience
-
Abstract Number: PB0308
Overall Haemostatic Potential Assay Can Detect Hypercoagulability and Hypofibrinolysis in Anticoagulated Patients Following Venous Thromboembolism
-
Abstract Number: OC 45.3
Overt DIC Score Predicts Mortality in Liver Insufficiency, a Comparison with the MELD-Na Score
ISTH 2021 Congress
July 17-21, 2021. Philadelphia, PA.